Robert Bauer is a Principal Scientist at Merck since September 2022, representing the Biochem/Biophysics core team for early and late-stage drug discovery in oncology and immunology. Prior experience includes serving as Associate Director at Agios Pharmaceuticals, where Robert focused on small molecule drug discovery for rare genetic diseases and managed assay development and CRO collaborations. Earlier roles at Agios consisted of Senior Scientist and Scientist, emphasizing biochemical assay development and small molecule screening. Robert's career began at New England Biolabs as a Postdoctoral Researcher, investigating DNA ligase kinetics, and as a Graduate Student Researcher at the University of Pittsburgh, exploring enzymatic functions in DNA replication. Robert holds a Ph.D. in Chemistry/Biochemistry from the University of Pittsburgh and a B.S. in Biochemistry from Indiana University of Pennsylvania.
This person is not in any teams
This person is not in any offices